Malignant neoplasms in cyclosporin A-induced autoimmunity (CyA-AI)

International Journal of Cancer

Volumn 72, Issue 3, 1997, Pages 530-535

  Wodzig, K Will H ^a,b   Beijleveld, Leo J J ^a   Damoiseaux, Jan G M C ^a   Arends, Jan Willem ^a   Van Breda Vriesman, Peter J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

ALOPECIA; ANIMALS; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; EPITHELIUM; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; MESODERM; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED LEW; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, CYTOTOXIC; THYMECTOMY; X-RAYS;

EID: 0030747684     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970729)72:3<530::AID-IJC24>3.0.CO;2-E     Document Type: Article

References (41)

1. ARMITAGE, J.O., Bone marrow transplantation. N. Engl. J. Med., 330, 827-838 (1994).
2. BAUHR, P., Multiple testing in clinical trials. Statist. Med., 10, 871-890 (1991).
3. BEIJLEVELD, L.J.J., DAMOISEAUX, J.G.M.C., WODZIG, K.W.H. and VAN BREDA VRIESMAN, P.J.C., X-irradiation of the thymus is not required for the induction of cyclosporin-induced autoimmunity. Transplantation, 59, 1601- 1605 (1995).
4. BOS, G.M.J., MAJOOR, G.D., WILLIGHAGEN, R.G.J. and VAN BREDA VRIESMAN, P.J.C., Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma. J. invest. Dermatol., 93, 610-615 (1989).
5. BRYSON, J.C., JENNINGS, C.D., CAYWOOD, B.E. and KAPLAN, A.M., Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation, 48, 1042-1047 (1989).
6. CALNE, R.Y., ROLLES, K., WHITE, D.J.G., THIRU, S., MCMASTER, P., CRADDOCK, G.N., AZIZ, S., EVANS, D.B., DUNN, D.C., HENDERSON, R.G. and LEWIS, P., Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet, 2, 1022-1033 (1979).
7. CHANG, A.E., ROSENBERG, S.A., GLATSTEIN, E.J. and ANTMAN, K.H., Sarcomas of soft tissue. In: V.T. DeVita Jr., S. Hellman and S.A. Rosenberg (eds.). Cancer. Principles and practice of oncology, pp. 1345-1398, J.B. Lippincott, Philadelphia (1989).
8. CHARAK, B.S., AGAH, R. and MAZUMDER, A., Synergism of interleukin-2 and cyclosporine A in induction of graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood, 80, 179-184 (1992).
9. CHENEY, R.T. and SPRENT, J., Capacity of cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transplant. Proc., 17, 528-530 (1985).
10. DAMOISEAUX, J.G.M.C., BEIJLEVELD, L.J.J. and VAN BREDA VRIESMAN, P.J.C., Multiple effects of cyclosporin-A on the thymus in relation to T-cell developement and autoimmunity. Clin. Immunol. Immunopathol., 82, 197-202 (1997).
11. DEHNER, L.D., Malignant fibrous histiocytoma. Nonspecific morphologic pattern, specific pathologic entity, or both? Arch. Pathol. Lab. Med., 112, 236-237 (1988).
12. DE VITA JR., V.T., HELLMAN, S. and ROSENBERG, S.A., Cancer. Principles and practice of oncology (3rd ed.), pp. 1469-1498 J.B. Lippincott, Philadelphia (1989).
13. FISCHER, A.C. and HESS, A.D., Age-related factors in cyclosporine-induced graft-versus-host disease: regulatory role of marrow-derived T lymphocytes. J. exp. Med., 172, 85-94 (1990).
14. GELLER, R.B., ESA, A.H., BESCHORNER, W.E., FRONDOZA, C.G., SANTOS, G.W. and HESS, A.D., Successful in vitro graft-versus-tumor effects against an Ia-bearing tumor using cyclosporin-induced syngeneic graft-versus-host disease in the rat. Blood, 74, 1165-1171 (1989).
15. GLAZIER, A., TUTSCHKA, P.J., FARMER, E.R. and SANTOS, G.W., Graft-versus- host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J. exp. Med., 158, 1-8 (1983).
16. HAJDU, S.I., Pathology of soft-tissue tumors, H. Kimpton, London (1979).
17. HATTORI, A., KUNZ, H.W., GILL III, T.J., PAN, S.F. and SHINOZUKA, H., Diversity of promoting action of cyclosporine on the induction of marine lymphoid tumors. Carcinogenesis, 9, 1091 (1988).
18. HATTORI, A., KUNZ, H.W., GILL III, T.J. and SHINOZUKA, H., Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine. Amer. J. Pathol., 128, 111-120 (1987).
19. HESS, A.D., HORWITZ, L., BESCHORNER, W.E. and SANTOS, G.W., Development of graft-versus-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J. exp. Med., 161, 718-730 (1985).
20. HESS, A.D., JONES, R.J., MORRIS, L.E., NOGA, S.J., VOGELSANG, G.B. and SANTOS, G.W., Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy. Hum. Immunol., 34, 219-224 (1992).
21. HOOD, A.F., VOGELSANG, G.B., BLACK, L.P., FARMER, E.R. and SANTOS, G.W., Acute graft-versus-host disease: development following autologous and syngeneic bone marrow transplantation. Arch. Dermatol., 123, 745- 750 (1987).
22. HOOGHE, R., JANOWSKI, M., GREIMERS, R. and SCHAAF-LAFONTAINE, N., Radiation-induced lymphomas developing during cyclosporine treatment. Transplantation, 48, 342-344 (1989).
23. JONES, R.J., HESS, A.D., MANN, R.B., PIANTADOSI, S., VOGELSANG, G.B., FARMER, E.R., GELLER, R.B. and SANTOS, G.W., Induction of graft-versus- host disease after autologous bone marrow transplantation. Lancet, 1, 754-757 (1989).
24. KELLY, G.E., MEILE, W. and SHEIL, A.G.R., Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation, 44, 29-433 (1987).
25. KENNEDY, M.J., VOGELSANG, G.B., BEVERIDGE, R.A., FARMER, E.R., ALTOMONTE, V., HUELSKAMP, A.M. and DAVIDSON, N.E., Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. clin. Oncol., 11, 478-484 (1993).
26. KENNEDY, M.J., VOGELSANG, G.B., JONES, R.J., FARMER, E.R., HESS, A.D., ALTOMONTE, V., HUELSKAMP, A.M. and DAVIDSON, N.E., Phase I trial of Interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. clin. Oncol., 12, 249-257 (1994).
27. LAND, C.E., Temporal distribution of risk for radiation-induced cancers. J. chron. Dis., 40 (Suppl. 2), 45S-57S (1987).
28. LEE, P., ALDERDICE, C. and WILKINSON, S., Malignancy in progressive systemic sclerosis. Association with breast carcinoma. J. Rheumatol., 10, 665-666 (1983).
29. PENN, I., Cancers following cyclosporine therapy. Transplantation, 43, 32-35 (1987).
30. PENN, I. and BRUNSON, M.E., Cancers after cyclosporin therapy. Transplant. Proc., 20, 885-889 (1989).
31. ROSENTHAL, A.K., MCLAUGHLIN, J.K., GRIDLEY, G. and NYRÉN. O., Incidence of cancer among patients with systemic sclerosis. Cancer, 76, 910-914 (1995).
32. ROUMM, A.D. and MEDSGER, T.A., Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheumatol., 28, 344-360 (1985).
33. RYFFEL, B., The carcinogenicity of cyclosporin. Toxicology, 73, 1-22 (1992).
34. RYFFEL, B., DONATSCH, P., MADORIN, M., MATTER, B.E., RUTTIMANN, G., SCHON, H., STOLL, R. and WILSON, J., Toxicological evaluation of cyclosporin A. Arch. Toxicol., 53, 107-141 (1983).
35. SANTOS, G.W., HESS, A.D. and VOGELSANG, G.B., Graft-versus-host reactions and disease. Immunol. Rev., 88, 169-192 (1985).
36. SCANLON, K.J., WANG, W. and HAN, H., Cyclosporin A supressess cisplatin-induced oncogene expression in human cancer cells. Cancer Treat. Rev., 17 (Suppl. A), 27-35 (1990).
37. SMITH, J., Postirradiation sarcoma of bone in Hodgkin disease. Skeletal Radiol., 16, 524-532 (1987).
38. UPTON, A., Biological aspects of radiation carcinogenesis. In: J.F.F. J.D. Boice Jr. (ed.), Radiation carcinogenesis: Epidemiology and biological significance, p. 9 Raven Press, New York (1984).
39. WODZIG, K.W.H., MAJOOR, G.D. and VAN BREDA VRIESMAN, P.J.C., On the localization of effector cells in cyclosporin-induced autoimmunity. Autoimmunity, 10, 275-283 (1991).
40. WODZIG, K.W.H., MAJOOR, G.D. and VAN BREDA VRIESMAN, P.J.C., Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats. Autoimmunity, 16, 29-37 (1993).
41. WRIGHT, S.P., Adjusted p-values for simultaneous interference. Biometrics, 48, 1005-1013 (1992).